What does accrued expenses and other liabilities mean?

This captures long-term obligations that do not fall under specific debt or insurance reserve categories, such as deferred compensation, long-term tax liabilities, or other contractual commitments. It represents the company's broader long-term financial obligations beyond core operational debt. Investors track this to understand the company's total long-term leverage and non-debt liability profile.

King Pharmaceuticals KG Accrued expenses and other liabilities

Accrued expenses and other liabilities at other companies

Midland States BancorpMSBI

$78.46M-28.4%

Hanmi FinancialHAFC

$74.58M-6.3%

DigitalBridge GroupDBRG

$615.37M-9.2%

ImaxIMAX

$88.14M-4.9%

CTO Realty GrowthCTO

$23.39M+17.0%

Century CommunitiesCCS

$276.77M-3.3%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's accrued expenses and other liabilities?: King Pharmaceuticals (KG) reported accrued expenses and other liabilities of $57.43M in Q1 2026.
What does accrued expenses and other liabilities mean?: This captures long-term obligations that do not fall under specific debt or insurance reserve categories, such as deferred compensation, long-term tax liabilities, or other contractual commitments. It represents the company's broader long-term financial obligations beyond core operational debt. Investors track this to understand the company's total long-term leverage and non-debt liability profile.